Case Report
Standardized cannabis in multiple sclerosis: a case report
-
* Corresponding author: Paul Hornby paul@hedron.ca
1 Department of Medical Cannabis Research, The Green Cross Society of BC, 2127, Kingsway, Vancouver, B.C., V5N 2T4, Canada
2 Department of Pathology and Laboratory Medicine, Heather Pavilion, Vancouver, General Hospital, Vancouver, B.C., Canada
Cases Journal 2010, 3:7 doi:10.1186/1757-1626-3-7
Published: 6 January 2010Abstract
A 52 year old female suffering from severe progressive multiple sclerosis was administered quantifiable amounts of standardized cannabis and monitored over the period of one year, while providing daily pain charts and records of her condition. An average daily intake of 500 mg of Tetrahydrocannabinol as cannabis was required to achieve a desired quality of life.